DK0852586T3 - Anvendelse af et 24 kDa-protein til behandling og diagnosticering af en HCV-infektion - Google Patents

Anvendelse af et 24 kDa-protein til behandling og diagnosticering af en HCV-infektion

Info

Publication number
DK0852586T3
DK0852586T3 DK96928648T DK96928648T DK0852586T3 DK 0852586 T3 DK0852586 T3 DK 0852586T3 DK 96928648 T DK96928648 T DK 96928648T DK 96928648 T DK96928648 T DK 96928648T DK 0852586 T3 DK0852586 T3 DK 0852586T3
Authority
DK
Denmark
Prior art keywords
hcv
diagnosis
treatment
hcv infection
kda protein
Prior art date
Application number
DK96928648T
Other languages
English (en)
Inventor
Sergio Abrignani
Original Assignee
Chiron Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Spa filed Critical Chiron Spa
Application granted granted Critical
Publication of DK0852586T3 publication Critical patent/DK0852586T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
DK96928648T 1995-09-01 1996-08-30 Anvendelse af et 24 kDa-protein til behandling og diagnosticering af en HCV-infektion DK0852586T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9517926.3A GB9517926D0 (en) 1995-09-01 1995-09-01 Binding protein
PCT/IB1996/000943 WO1997009349A1 (en) 1995-09-01 1996-08-30 Binding protein

Publications (1)

Publication Number Publication Date
DK0852586T3 true DK0852586T3 (da) 2003-11-03

Family

ID=10780099

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96928648T DK0852586T3 (da) 1995-09-01 1996-08-30 Anvendelse af et 24 kDa-protein til behandling og diagnosticering af en HCV-infektion

Country Status (14)

Country Link
US (4) US6737233B1 (da)
EP (2) EP0852586B1 (da)
JP (3) JP4223074B2 (da)
AT (2) ATE245166T1 (da)
AU (1) AU712540B2 (da)
CA (1) CA2227301C (da)
DE (2) DE69635535T2 (da)
DK (1) DK0852586T3 (da)
ES (1) ES2202459T3 (da)
GB (1) GB9517926D0 (da)
IL (1) IL123169A (da)
NZ (1) NZ316186A (da)
PT (1) PT852586E (da)
WO (1) WO1997009349A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416671D0 (en) * 1994-08-17 1994-10-12 Biocine Spa Assay
PT1021534E (pt) 1997-10-06 2010-03-03 Novartis Vaccines & Diagnostic Proteina cd81 receptora da hepatite c
GB9927320D0 (en) 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US8647887B2 (en) 2009-01-29 2014-02-11 Commonwealth Scientific And Industrial Research Organisation Measuring G protein coupled receptor activation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1049686C (zh) 1987-11-18 2000-02-23 希龙股份有限公司 非ａ和非ｂ肝炎病毒的诊断及疫苗
KR0185373B1 (ko) 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
US5308750A (en) * 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
EP0565172A1 (en) * 1992-04-10 1993-10-13 Quest International B.V. Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity
US5622861A (en) * 1994-08-05 1997-04-22 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA encoding hepatitis A virus receptor
GB9416671D0 (en) 1994-08-17 1994-10-12 Biocine Spa Assay
WO2002022155A1 (en) * 2000-09-13 2002-03-21 Hawaii Biotechnology Group, Inc. Immunogenic composition of hepatitis c and methods of use thereof

Also Published As

Publication number Publication date
ATE245166T1 (de) 2003-08-15
PT852586E (pt) 2003-12-31
US6777538B2 (en) 2004-08-17
CA2227301C (en) 2013-08-27
JP2000500004A (ja) 2000-01-11
EP0852586A1 (en) 1998-07-15
JP2008079613A (ja) 2008-04-10
AU6835196A (en) 1997-03-27
AU712540B2 (en) 1999-11-11
DE69635535D1 (de) 2006-01-05
CA2227301A1 (en) 1997-03-13
DE69629121D1 (de) 2003-08-21
IL123169A0 (en) 1998-09-24
EP0852586B1 (en) 2003-07-16
EP1321476A2 (en) 2003-06-25
DE69629121T2 (de) 2004-05-27
GB9517926D0 (en) 1995-11-01
US20010027565A1 (en) 2001-10-04
NZ316186A (en) 1999-09-29
IL123169A (en) 2001-10-31
ES2202459T3 (es) 2004-04-01
EP1321476A3 (en) 2003-08-13
DE69635535T2 (de) 2006-08-17
US6737233B1 (en) 2004-05-18
US7026130B2 (en) 2006-04-11
US20060166193A1 (en) 2006-07-27
WO1997009349A1 (en) 1997-03-13
JP2007039462A (ja) 2007-02-15
JP4223074B2 (ja) 2009-02-12
EP1321476B1 (en) 2005-11-30
ATE311408T1 (de) 2005-12-15
US20040180053A1 (en) 2004-09-16
US7320875B2 (en) 2008-01-22

Similar Documents

Publication Publication Date Title
DE3583293D1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
DK0770679T4 (da) HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf
SE9004010A (sv) Viralt medel
DK0754704T3 (da) Syntetiske antigener til påvisning af antistoffer mod hepatitis c-virus
DK0935609T3 (da) Krystalliserbare præparater omfattende et hepatitis-C-virus-NS3-proteasedomæne/NS4A-kompleks og dermed opnåede krystaller
DK0500108T3 (da) Forbedret aktivering af rekombinante proteiner
DK0554389T4 (da) Molekylære kloner af HIV-1 og anvendelse deraf
DK0937153T3 (da) Humane monoklonale antistoffer, der er specifikke for hepatitis C-virus (HCV) E2 antigen
DE69836758D1 (de) Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv
DK0852586T3 (da) Anvendelse af et 24 kDa-protein til behandling og diagnosticering af en HCV-infektion
DK0972781T3 (da) Protein S-polypeptider og anvendelser deraf
DE60034243D1 (de) Rekombinante bifunktionale fusionsproteine zur abtreibung variabler viren
IT1270941B (it) Peptidi di hcv e loro usi.